New perspectives in neurosteroid action: open questions for future research.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4168719)

Published in Front Cell Neurosci on September 19, 2014

Authors

Rainer Rupprecht1

Author Affiliations

1: Department of Psychiatry and Psychotherapy, University of Regensburg Regensburg, Germany.

Articles cited by this

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci (1999) 2.76

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov (2010) 2.68

Neurosteroids act on recombinant human GABAA receptors. Neuron (1990) 2.44

Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology (2013) 2.16

Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science (2009) 1.61

Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) (2006) 1.48

Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J Biol Chem (2014) 1.21

Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor. Mol Pharmacol (2012) 1.05

The role of allopregnanolone in depression and anxiety. Prog Neurobiol (2013) 1.04

Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis. J Neuroinflammation (2014) 1.03

Recent advances in the pharmacotherapy of infantile spasms. CNS Drugs (2014) 0.97

Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch Gen Psychiatry (2003) 0.94

Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl) (2014) 0.92

Allopregnanolone and mood disorders. Prog Neurobiol (2013) 0.92

Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans. Biol Psychiatry (2012) 0.85

The translocator protein as a drug target in Alzheimer's disease. Expert Rev Neurother (2014) 0.83

Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain. Prog Neurobiol (2013) 0.81